XML 18 R4.htm IDEA: XBRL DOCUMENT v3.10.0.1
CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
 12 Months Ended
Sep. 30, 2018
Sep. 30, 2017
Sep. 30, 2016
Operating expenses      
General and administrative $ 5,989,170 $ 5,008,275 $ 8,334,740
Research and development 13,344,421 10,672,086 7,254,303
Total operating expenses (19,333,591) (15,680,361) (15,589,043)
Other income (expenses)      
Grant income 149,055 140,942 141,195
Research and development incentive income 1,629,513 2,022,902 571,093
Interest income 255,092 88,098 11,322
Gain on settlement of accounts payable 75,204 151,402
Gain on settlement of debt 61,205
Financing related charges (30,943) (5,812)
Foreign exchange loss, net (49,789) (47,583) (48,445)
Total other income (expense), net 1,952,928 2,279,563 881,960
Net loss before provision for income taxes (17,380,663) (13,400,798) (14,707,083)
Income tax expense 72,746 59,607 29,615
Net loss and comprehensive loss $ (17,453,409) $ (13,460,405) $ (14,736,698)
Loss per share Basic and diluted (in dollars per share) $ (0.39) $ (0.33) $ (0.42)
Weighted average number of shares outstanding Basic and diluted (in shares) 44,655,725 40,841,033 35,153,426